Host control comprises the immune reactions of an infected host to an infection.
Detailed description
Host control can, for example, refer to the degree to which an individual is able to fight replication of an infecting virus. The extent of host control determines whether a virus elicits symptoms in the host at all.
INCATE, the INCubator for Antibacterial Therapies in Europe, and BIOASTER, the French Technology Research Institute, have announced this week the beginning of a new partnership that aims to improve
Every year at least 700,000 people die as a result of infection with antibiotic-resistant bacteria—a figure which according to WHO forecasts could rise to ten million people by 2050 without new
Please use image only in conjunction with press release.
Antibiotics affect the composition and dynamics of the gut microbiome. Treatment with antibiotics not only leads to a loss of biodiversity of microorganisms, but also often favours the selection of
It was previously believed that herpesviruses use certain body cells to replicate and other body cells to remain dormant, that is to remain inactive for a longer period of time. This dogma is now
The INCubator for Antibacterial Therapies in Europe, INCATE, aims to support innovators in the early stages of developing therapies in the field of antimicrobial resistance. The German Center for
Scanning electron micrograph: C. difficile cells were provided by Nicole Metzendorf from the Department of Microbial Physiology and Molecular Biology, Institute of Microbiology, and imaged by Rabea Schlüter, Imaging Center of the Department of Biology, University of Greifswald, Germany.
Please use this image only in connection with this press release.
Infections with the bacterium Clostridioides difficile (C. difficile for short) frequently recur due to permanent stages remaining in the intestine. A drug that also effectively combats the permanent
Potentially life-threatening infectious diseases (such as HIV/AIDS at the time) were among the first indications for gene therapy as early as the 1990s. Today, cell and gene therapy strategies are
Current developments in infection research challenge the scientific community: Many problems can only be solved if expertise from different disciplines comes together. To meet this challenge, the DZIF
Please use this image only in connection with this press release.
Effective drugs against viral diseases like COVID-19 are urgently needed now and in the future. The emergence of viral mutants and yet unknown viruses could push vaccines to their limits. The DZIF
Symposium
World Conference Center Bonn Platz der Vereinten Nationen 2 53113Bonn Germany
